109 related articles for article (PubMed ID: 23563039)
1. Effect of cyclophosphamide and morin-5'-sulfonic acid sodium salt, alone or in combination, on ADMA/DDAH pathway in rats.
Merwid-Ląd A; Trocha M; Chlebda-Sieragowska E; Sozański T; Magdalan J; Ksiądzyna D; Szuba A; Kopacz M; Kuźniar A; Nowak D; Pieśniewska M; Fereniec-Gołębiewska L; Szeląg A
Pharmacol Rep; 2013; 65(1):201-7. PubMed ID: 23563039
[TBL] [Abstract][Full Text] [Related]
2. Effects of morin-5'-sulfonic acid sodium salt (NaMSA) on cyclophosphamide-induced changes in oxido-redox state in rat liver and kidney.
Merwid-Ląd A; Trocha M; Chlebda E; Sozański T; Magdalan J; Ksiądzyna D; Kopacz M; Kuźniar A; Nowak D; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A
Hum Exp Toxicol; 2012 Aug; 31(8):812-9. PubMed ID: 22241626
[TBL] [Abstract][Full Text] [Related]
3. Impact of morin-5'-sulfonic acid sodium salt on cyclophosphamide-induced gastrointestinal toxicity in rats.
Merwid-Ląd A; Ksiądzyna D; Hałoń A; Chlebda-Sieragowska E; Trocha M; Szandruk M; Sozański T; Magdalan J; Kopacz M; Kuźniar A; Nowak D; Pieśniewska M; Szeląg A
Pharmacol Rep; 2015 Dec; 67(6):1259-63. PubMed ID: 26481550
[TBL] [Abstract][Full Text] [Related]
4. Effect of quercetin-5'-sulfonic acid sodium salt on SOD activity and ADMA/DDAH pathway in extracorporeal liver perfusion in rats.
Trocha M; Merwid-Lad A; Szuba A; Sozański T; Magdalan J; Szelag A; Kopacz M; Kuźniar A; Nowak D
Adv Clin Exp Med; 2012; 21(4):423-31. PubMed ID: 23240447
[TBL] [Abstract][Full Text] [Related]
5. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
6. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
Davids M; Richir MC; Visser M; Ellger B; van den Berghe G; van Leeuwen PA; Teerlink T
Metabolism; 2012 Apr; 61(4):482-90. PubMed ID: 22000584
[TBL] [Abstract][Full Text] [Related]
7. GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans.
Chobanyan K; Thum T; Suchy MT; Zhu B; Mitschke A; Gutzki FM; Beckmann B; Stichtenoth DO; Tsikas D
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):32-41. PubMed ID: 17825631
[TBL] [Abstract][Full Text] [Related]
8. Influence of ezetimibe on ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Sozański T; Ewa Chlebda-Sieragowska E; Szuba A; Dzięgiel P; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Gomułkiewicz A; Cwynar-Zając Ł; Brykner R; Szeląg A
Pharmacol Rep; 2013; 65(1):122-33. PubMed ID: 23563030
[TBL] [Abstract][Full Text] [Related]
9. Effect of morin-5'-sulfonic acid sodium salt on the expression of apoptosis related proteins caspase 3, Bax and Bcl 2 due to the mercury induced oxidative stress in albino rats.
Venkatesan RS; Sadiq AM
Biomed Pharmacother; 2017 Jan; 85():202-208. PubMed ID: 27919736
[TBL] [Abstract][Full Text] [Related]
10. Modulation of arginine and asymmetric dimethylarginine concentrations in liver and plasma by exogenous hydrogen sulfide in LPS-induced endotoxemia.
Bekpinar S; Develi-Is S; Unlucerci Y; Kusku-Kiraz Z; Uysal M; Gurdol F
Can J Physiol Pharmacol; 2013 Dec; 91(12):1071-5. PubMed ID: 24289078
[TBL] [Abstract][Full Text] [Related]
11. The impact of sitagliptin, inhibitor of dipeptidyl peptidase-4 (DPP-4), on the ADMA-DDAH-NO pathway in ischemic and reperfused rat livers.
Trocha M; Nowak B; Merwid-Ląd A; Szuba A; Dzięgiel P; Pieśniewska M; Gomułkiewicz A; Wiśniewski J; Piasecki T; Gziut M; Szeląg A; Sozański T
Adv Clin Exp Med; 2018 Nov; 27(11):1483-1490. PubMed ID: 30303311
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
Wakino S; Hayashi K; Tatematsu S; Hasegawa K; Takamatsu I; Kanda T; Homma K; Yoshioka K; Sugano N; Saruta T
Hypertens Res; 2005 Mar; 28(3):255-62. PubMed ID: 16097370
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
Yuan Q; Peng J; Liu SY; Wang CJ; Xiang DX; Xiong XM; Hu CP; Li YJ
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):630-5. PubMed ID: 20132235
[TBL] [Abstract][Full Text] [Related]
14. Icariin regulates PRMT/ADMA/DDAH pathway to improve endothelial function.
Xiao HB; Liu ZK; Lu XY; Deng CN; Luo ZF
Pharmacol Rep; 2015 Dec; 67(6):1147-54. PubMed ID: 26481534
[TBL] [Abstract][Full Text] [Related]
15. The impact of morin, a natural flavonoid, on cyclophosphamide-induced changes in the oxidative stress parameters in rat livers.
Merwid-Ląd A; Trocha M; Chlebda-Sieragowska E; Sozański T; Szandruk M; Magdalan J; Ksiądzyna D; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A
Adv Clin Exp Med; 2014; 23(4):505-9. PubMed ID: 25166433
[TBL] [Abstract][Full Text] [Related]
16. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
Lin KY; Ito A; Asagami T; Tsao PS; Adimoolam S; Kimoto M; Tsuji H; Reaven GM; Cooke JP
Circulation; 2002 Aug; 106(8):987-92. PubMed ID: 12186805
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
Matsuguma K; Ueda S; Yamagishi S; Matsumoto Y; Kaneyuki U; Shibata R; Fujimura T; Matsuoka H; Kimoto M; Kato S; Imaizumi T; Okuda S
J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological activation of dimethylarginine dimethylaminohydrolase (DDAH) activity by inorganic nitrate and DDAH inhibition by N
Bollenbach A; Tsikas D
Amino Acids; 2019 Mar; 51(3):483-494. PubMed ID: 30536052
[TBL] [Abstract][Full Text] [Related]
19. SZSJ protects against insomnia by a decrease in ADMA level and an improvement in DDAH production in sleep-deprived rats.
Xiao HB; Wang YS; Luo ZF; Lu XY
Life Sci; 2018 Sep; 209():97-102. PubMed ID: 30048696
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T
Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
